2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO29] Mini-Oral Session 29　Lung Cancer / Thoracic Cancer 4（EGFR-TKI 1）
【E】

Fri. Feb 18, 2022 9:55 AM - 10:45 AM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair：Kazuma Kishi（Department of Respiratory Medicine, Toho University），Toshiyuki Kozuki（Clinical Research Center, National Hospital Organization Shikoku Cancer Center）

[MO29-5] Updated safety and efficacy of poziotinib in Japanese patients with non-small cell lung cancer: Phase 1 study

○Akira Ono1, Haruko Daga2, Kyounghwa Bae3, Lyndah Dreiling3, Francois Lebel3, Koichi Goto4 (1.Head Physician Dept of Respiratory Medicine and Thoracic Oncology Shizuoka Cancer Center, 2.Director, Department of Medical Oncology, Osaka City General Hospital, 3.Spectrum Pharmaceuticals, Inc., 4.Chief, Department of Thoracic Oncology, National Cancer Center Hospital East Principal Investigator of LC-SCRUM-Asia)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password